CoChat

Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy

Open access

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; none of the 47 sources its claims cite is checked for support yet.

Abstract

BACKGROUND: mRNA electroporation of dendritic cells (DCs) facilitates processing and presentation of multiple peptides derived from whole antigen, tailored to different HLA molecules. Clinical responses to electroporated moDC vaccines, however, have been suboptimal. Human Langerhans-type DCs (LCs) are the most potent conventional DC subtype for inducing CD8+ cytotoxic T lymphocytes (CTLs) in vitro. We recently demonstrated that Wilms' tumor 1 (WT1) mRNA-electroporated LCs are superior to moDCs as stimulators of tumor antigen-specific CD8+ CTLs, even though they are comparable stimulators of allogeneic T cell proliferative responses. A detailed comparative evaluation of the effects of mRNA electroporation on LCs versus moDCs, however, is needed. METHODS: Immature and partially-matured human moDCs and LCs electroporated with mRNA were compared for transfection efficiency, phenotypic changes, viability, retention of transgene expression after cryopreservation, and immunogenicity. Student t test was used for each pairwise comparison. One-way analysis of variance was used for multiple group comparisons. RESULTS: Transfection efficiency after electroporation with enhanced green fluorescent protein (eGFP) mRNA was higher for immature than for partially-matured moDCs. In contrast, transfection efficiency was higher for partially-matured than for immature LCs, with the additional benefit that electroporation itself increased maturation and activation of CD83+HLA-DRbright LCs but not moDCs. Electroporation did not impair final maturation and activation of either DC subtype, after which both mRNA-electroporated LCs and moDCs were functionally similar in stimulating allogeneic T cell proliferation, a standard assay of DC immunogenicity. CONCLUSIONS: These findings support mRNA electroporation of DCs, and in particular LCs, as an effective non-viral method to stimulate specific, potent CD8+ CTL responses. The differences between LCs and moDCs regarding this form of antigen-loading have important implications for DC-based immunotherapies.

Overview

CoChat Summary

TL;DR

mRNA electroporation of human dendritic cells is feasible, but transfection efficiency and maturation effects differ by DC subtype and maturation state: immature moDCs transfect better than partially matured moDCs, whereas partially matured LCs transfect better than immature LCs, and electroporation itself matures LCs more than moDCs. Both mRNA-electroporated moDCs and LCs remain viable, retain transgene expression after cryopreservation, and stimulate allogeneic T cell proliferation similarly.

Key findings

  • Transfection efficiency after eGFP mRNA electroporation was higher for immature than partially-matured moDCs (peak at 24 hours: 77.9 ± 12.4% vs 59.4 ± 15.4%), but higher for partially-matured than immature LCs (peak at 48 hours: 67 ± 6.9% vs 55.2 ± 2.9%).
  • Electroporation increased maturation/activation markers more strongly in LCs than moDCs: CD83+HLA-DRbright LCs rose from 29.62 ± 2.8% pre-electroporation to 96.92 ± 0.81% post-electroporation, whereas moDC CD83 rose from 10.68 ± 3.37% to 26.13 ± 3.34%; CD80 increased from 33.36 ± 1.65% to 77.03 ± 5.54% for LCs and from 4.9 ± 2.1% to 35.88 ± 7.11% for moDCs (fold increase 2.3 for LCs vs 7.3 for moDCs). Electroporation did not impair terminal cytokine-induced maturation of either subtype.
  • Electroporation caused up to approximately 40% initial cell death, but after 24 hours viability was >85% for immature and partially-matured moDCs and LCs (e.g., 94.2 ± 3.0% for immature moDCs, 88.7 ± 6.3% for immature LCs, 87.1 ± 7.1% for partially-matured moDCs, 92.9 ± 3.8% for partially-matured LCs). Post-thaw viability and retention of eGFP expression after cryopreservation were similar between moDCs and LCs.
  • mRNA-electroporated moDCs and LCs remained potent stimulators of allogeneic T cell proliferation in mixed leukocyte reactions, including after cryopreservation and thawing, with similar trends across mock-, eGFP mRNA-, and WT1 mRNA-electroporated DCs.

Methods

  • Immature and partially-matured human moDCs were generated from PBMCs/CD14+ monocytes, and LCs were generated from G-CSF–elicited CD34+ hematopoietic progenitor cells; cells were electroporated with eGFP or WT1 mRNA and compared for transfection efficiency, phenotype, viability, cryopreservation retention, and allogeneic stimulatory capacity.
  • Flow cytometry assessed eGFP and CD80/CD83/CD86/HLA-DR expression; viability was measured by trypan blue exclusion; allogeneic mixed leukocyte reactions used [3H]TdR uptake or a colorimetric proliferation assay.
  • Student t test was used for pairwise comparisons, one-way ANOVA for multiple group comparisons, with P < .05 considered significant; independent experiment numbers included n = 6 for transfection, n = 3 for phenotype/MLR, and n = 4 for viability/cryopreservation assays.

Limitations

  • Stated: peak transfection efficiency was lower for LCs than moDCs, possibly because moDCs derive from a more differentiated and committed starting population with greater purity, leaving contaminating non-LCs to compete for mRNA uptake; HLA-DR selection could increase LC transfection efficiency but may not be necessary if electroporated LCs are quantified by flow cytometry.
  • Stated: electroporation conditions need revalidation across differences in electroporation machine, voltage, pulse number, cell concentration, or mRNA amount; cryopreservation can further decrease cell recovery, so excess electroporated DCs should be aliquoted. The paper also notes additional undiscovered reasons for LC potency and states it remains important to determine whether IL15-supplemented moDCs are an adequate substitute for LCs or whether the two subtypes should be combined.
  • Evident from the text: the functional comparison here is allogeneic T cell proliferation, not antigen-specific CD8+ CTL killing or in vivo clinical responses; the study is in vitro, with small independent experiment numbers, and does not itself test mRNA-electroporated LC versus moDC vaccines in patients.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/1479-5876-11-166

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 The maturation status of moDCs and LCs affects mRNA-electroporation transfection efficiency. Immature (□) and partially-matured (▤) moDCs (A, C) and LCs (B, D) were electroporated with eGFP-encoding mRNA. The transfection efficiency for each experimental group was assessed by flow cytometry at the indicated time points. Pooled data (mean ± SD, n = 6 independent experiments) are shown for moDCs (A) and LCs (B). *P < .05 and **P < .01 for comparisons between immature and mature groups. Representative histograms of eGFP mRNA-electroporated immature moDCs (C) and partially-matured LCs (D) from one of six independent experiments are shown.
Figure 1 The maturation status of moDCs and LCs affects mRNA-electroporation transfection efficiency. Immature (□) and partially-matured (▤) moDCs (A, C) and LCs (B, D) were electroporated with eGFP-encoding mRNA. The transfection efficiency for each experimental group was assessed by flow cytometry at the indicated time points. Pooled data (mean ± SD, n = 6 independent experiments) are shown for moDCs (A) and LCs (B). *P < .05 and **P < .01 for comparisons between immature and mature groups. Representative histograms of eGFP mRNA-electroporated immature moDCs (C) and partially-matured LCs (D) from one of six independent experiments are shown.CC BY · PubMed Central
Figure 2 Optimization of mRNA-electroporation conditions. Immature moDCs (A-C) and partially-matured LCs (D-F) were electroporated with eGFP-encoding mRNA under different conditions of set voltage, number of electroporation pulses, or amount of mRNA. Only one of the three parameters was varied in any given set of tested conditions, as summarized in each panel. Cells were assessed for viability (○) by trypan blue exclusion and transfection efficiency (▤) by flow cytometry.
Figure 2 Optimization of mRNA-electroporation conditions. Immature moDCs (A-C) and partially-matured LCs (D-F) were electroporated with eGFP-encoding mRNA under different conditions of set voltage, number of electroporation pulses, or amount of mRNA. Only one of the three parameters was varied in any given set of tested conditions, as summarized in each panel. Cells were assessed for viability (○) by trypan blue exclusion and transfection efficiency (▤) by flow cytometry.CC BY · PubMed Central
Figure 3 mRNA electroporation induces the maturation and activation of LCs to a greater magnitude than for moDCs. Immature moDCs and LCs were electroporated with eGFP mRNA and then cultured with (+) or without (−) standard maturation-inducing inflammatory cytokines. After 24 hours, cells in each experimental group were compared with pre-electroporation controls by flow cytometry for the expression of phenotypic markers of DC maturation and activation, based on the upregulation of (A) CD83, (B) CD80, and (C) CD86, respectively. Representative dot plots of eGFP mRNA-electroporated moDCs and LCs from one of three independent experiments are shown in the top row. Pooled data for each experimental group (mean ± SD, n = 3 independent experiments) are shown in the bottom row (gray bar = pre-electroporation control, white bar = post-electroporation without inflammatory cytokines, black bar = post-electroporation with inflammatory cytokines). *P < .05, **P < .01, ***P < .001, relative to pre-electroporation control, except where brackets indicate comparisons between post-electroporation groups.
Figure 3 mRNA electroporation induces the maturation and activation of LCs to a greater magnitude than for moDCs. Immature moDCs and LCs were electroporated with eGFP mRNA and then cultured with (+) or without (−) standard maturation-inducing inflammatory cytokines. After 24 hours, cells in each experimental group were compared with pre-electroporation controls by flow cytometry for the expression of phenotypic markers of DC maturation and activation, based on the upregulation of (A) CD83, (B) CD80, and (C) CD86, respectively. Representative dot plots of eGFP mRNA-electroporated moDCs and LCs from one of three independent experiments are shown in the top row. Pooled data for each experimental group (mean ± SD, n = 3 independent experiments) are shown in the bottom row (gray bar = pre-electroporation control, white bar = post-electroporation without inflammatory cytokines, black bar = post-electroporation with inflammatory cytokines). *P < .05, **P < .01, ***P < .001, relative to pre-electroporation control, except where brackets indicate comparisons between post-electroporation groups.CC BY · PubMed Central
Figure 4 Cell recovery and viability of moDCs and LCs after electroporation and cryopreservation. Immature (□) and partially-matured (▤) moDCs and LCs were electroporated with eGFP-encoding mRNA, without purification by HLA-DR selection a priori. (A) Immediate post-electroporation viable cell recovery relative to the total number of cells electroporated was assessed by trypan blue exclusion (mean ± SD, n = 4 independent experiments). (B) Surviving cells from (A) were returned to culture, and cell viability was assessed 24 hours after electroporation, relative to initial number of cells returned to culture after electroporation (mean ± SD, n = 4 independent experiments). (C) After at least 24 hours in culture, cells from (B) were cryopreserved. Upon subsequent thawing, immediate post-thaw viability was assessed relative to initial number of cells frozen (mean ± SD, n = 4 independent experiments). (D) After 24 hours in culture, thawed cells from (C) were reassessed for viability (mean ± SD, n = 4 independent experiments).
Figure 4 Cell recovery and viability of moDCs and LCs after electroporation and cryopreservation. Immature (□) and partially-matured (▤) moDCs and LCs were electroporated with eGFP-encoding mRNA, without purification by HLA-DR selection a priori. (A) Immediate post-electroporation viable cell recovery relative to the total number of cells electroporated was assessed by trypan blue exclusion (mean ± SD, n = 4 independent experiments). (B) Surviving cells from (A) were returned to culture, and cell viability was assessed 24 hours after electroporation, relative to initial number of cells returned to culture after electroporation (mean ± SD, n = 4 independent experiments). (C) After at least 24 hours in culture, cells from (B) were cryopreserved. Upon subsequent thawing, immediate post-thaw viability was assessed relative to initial number of cells frozen (mean ± SD, n = 4 independent experiments). (D) After 24 hours in culture, thawed cells from (C) were reassessed for viability (mean ± SD, n = 4 independent experiments).CC BY · PubMed Central
Figure 5 mRNA-electroporated moDCs and LCs retain eGFP expression after cryopreservation. Immature (□) and partially-matured (▤) moDCs and LCs were electroporated with eGFP mRNA and cryopreserved. After thawing, eGFP expression for each experimental group was measured by flow cytometry and compared with pre-cryopreservation eGFP expression values to determine percent retention of eGFP expression. Pooled data are shown for each experimental group (mean ± SD, n = 3 independent experiments, ns = not significant).
Figure 5 mRNA-electroporated moDCs and LCs retain eGFP expression after cryopreservation. Immature (□) and partially-matured (▤) moDCs and LCs were electroporated with eGFP mRNA and cryopreserved. After thawing, eGFP expression for each experimental group was measured by flow cytometry and compared with pre-cryopreservation eGFP expression values to determine percent retention of eGFP expression. Pooled data are shown for each experimental group (mean ± SD, n = 3 independent experiments, ns = not significant).CC BY · PubMed Central
Figure 6 mRNA-electroporated moDCs and LCs remain potent inducers of allogeneic T cell proliferation, including after cryopreservation and thawing. (A) MoDCs and LCs, as indicated on the x axes, were electroporated with WT1 mRNA (○), eGFP mRNA (△), or mock-electroporated with no mRNA (□). After electroporation, DCs were terminally matured for 24 hours and then cultured with allogeneic T cells for five days in allogeneic MLRs. DC:T ratios ranged from 1:10 to 1:1000. [3H]TdR uptake by proliferating allogeneic T cells over the final 8 hours of culture was measured as an index of DC immunogenicity (triplicate means ± SEM, n = 3 independent experiments). (B) To assess preservation of allo-stimulatory capacity in MLRs after cryopreservation and thawing, WT1 mRNA-electroporated moDCs (△) and LCs (○) were compared with non-cryopreserved mature moDCs (▤). Culture conditions were otherwise exactly the same as in (A). T cell proliferation was measured by a colorimetric assay (triplicate means ± SEM, n = 3 independent experiments). Dotted line represents T cells alone.
Figure 6 mRNA-electroporated moDCs and LCs remain potent inducers of allogeneic T cell proliferation, including after cryopreservation and thawing. (A) MoDCs and LCs, as indicated on the x axes, were electroporated with WT1 mRNA (○), eGFP mRNA (△), or mock-electroporated with no mRNA (□). After electroporation, DCs were terminally matured for 24 hours and then cultured with allogeneic T cells for five days in allogeneic MLRs. DC:T ratios ranged from 1:10 to 1:1000. [3H]TdR uptake by proliferating allogeneic T cells over the final 8 hours of culture was measured as an index of DC immunogenicity (triplicate means ± SEM, n = 3 independent experiments). (B) To assess preservation of allo-stimulatory capacity in MLRs after cryopreservation and thawing, WT1 mRNA-electroporated moDCs (△) and LCs (○) were compared with non-cryopreserved mature moDCs (▤). Culture conditions were otherwise exactly the same as in (A). T cell proliferation was measured by a colorimetric assay (triplicate means ± SEM, n = 3 independent experiments). Dotted line represents T cells alone.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 20 Not checked · 40 Own results and interpretations

24 more claims

Create a free account to see all 60 claims and to verify the 47 references still open.

See all claims — free account
  • Probably not a substantial claim. 18
  • It may state two separate claims as one. 18
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 26 references

Cited by

See all 24

Metadata

Authors
Chung, D. J., Romano, E., Pronschinske, K. B., Shyer, J. A., Mennecozzi, M., Angelo, E. T. S., & Young, J. W.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Chung, David J
Venue
Journal of Translational Medicine
Published
2013-07-09
Volume
11
Issue
1
Pages
166-166
ISSN
1479-5876 (ISSN-L)
OpenAlex
W2108060874
Cited by
24
References
26
Citations by year
2026: 2 · 2025: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2017: 2 · 2016: 4 · 2014: 6 · 2013: 1
FWCI
1.32
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense
  • Memorial Sloan-Kettering Cancer Center
  • Swim Across America
  • European Commission (21027)
  • Centre Hospitalier Universitaire Vaudois
  • National Institutes of Health
  • Weill Cornell Medical College
  • Joint Research Centre
  • National Cancer Institute (P01CA023766, R01CA118974, R01CA083070, R21CA119528, P30CA008748)
  • Congressionally Directed Medical Research Programs
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Microbial Inactivation Methods
Keywords
dendritic cells, Langerhans cells, monocyte-derived dendritic cells, mRNA electroporation, dendritic cell maturation, dendritic cell activation, transfection efficiency, WT1 mRNA, CD8+ cytotoxic T lymphocytes, allogeneic T cell proliferation, dendritic cell immunotherapy, cryopreservation
MeSH terms
Cell Survival, Dendritic Cells, HLA Antigens, Humans, Immunotherapy, Islets of Langerhans, Monocytes, Phenotype, RNA, Messenger, T-Lymphocytes, Cytotoxic, Transfection, Granulocyte Colony-Stimulating Factor, Cytokines, Antigen Presentation, Electroporation, Transgenes, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy. https://app.cochat.ai/papers/10.1186/1479-5876-11-166
The paper
Chung, D. J., Romano, E., Pronschinske, K. B., Shyer, J. A., Mennecozzi, M., Angelo, E. T. S., & Young, J. W. (2013). Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-11-166

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.